These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 2819727)
1. DNA topoisomerases: from a laboratory curiosity to a subject in cancer chemotherapy. Wang JC NCI Monogr; 1987; (4):3-6. PubMed ID: 2819727 [TBL] [Abstract][Full Text] [Related]
2. [DNA supercoiling and topoisomerases in Escherichia coli]. Gómez-Eichelmann MC; Camacho-Carranza R Rev Latinoam Microbiol; 1995; 37(3):291-304. PubMed ID: 8850348 [TBL] [Abstract][Full Text] [Related]
3. Analysis of eukaryotic DNA topoisomerases and topoisomerase-directed drug effects. Boege F Eur J Clin Chem Clin Biochem; 1996 Nov; 34(11):873-88. PubMed ID: 8960461 [TBL] [Abstract][Full Text] [Related]
4. [Poisons of DNA topoisomerases I and II]. Charcosset JY; Soues S; Laval F Bull Cancer; 1993 Nov; 80(11):923-54. PubMed ID: 8081034 [TBL] [Abstract][Full Text] [Related]
6. DNA topoisomerases and topoisomerase inhibitors. Giaccone G Pathol Biol (Paris); 1994 Apr; 42(4):346-52. PubMed ID: 7808789 [TBL] [Abstract][Full Text] [Related]
7. Increased sensitivity to quinolone antibacterials can be engineered in human topoisomerase IIalpha by selective mutagenesis. Hammonds TR; Foster SR; Maxwell A J Mol Biol; 2000 Jul; 300(3):481-91. PubMed ID: 10884345 [TBL] [Abstract][Full Text] [Related]
8. Human DNA topoisomerase II: biochemistry and role in chemotherapy resistance (review). Withoff S; De Jong S; De Vries EG; Mulder NH Anticancer Res; 1996; 16(4A):1867-80. PubMed ID: 8712715 [TBL] [Abstract][Full Text] [Related]
9. [Biological function of DNA topoisomerases and its implication in cancer chemotherapy]. Andoh T; Okada K; Oguro M Gan To Kagaku Ryoho; 1988 Jan; 15(1):1-14. PubMed ID: 2827584 [TBL] [Abstract][Full Text] [Related]
10. An atypical type II topoisomerase from Mycobacterium smegmatis with positive supercoiling activity. Jain P; Nagaraja V Mol Microbiol; 2005 Dec; 58(5):1392-405. PubMed ID: 16313624 [TBL] [Abstract][Full Text] [Related]
11. Topoisomerase II as a target for anticancer chemotherapy. Kaufmann SH; Hancock R Acta Biochim Pol; 1995; 42(4):381-93. PubMed ID: 8852329 [TBL] [Abstract][Full Text] [Related]
12. Topoisomerases of kinetoplastid parasites: why so fascinating? Das BB; Sengupta T; Ganguly A; Majumder HK Mol Microbiol; 2006 Nov; 62(4):917-27. PubMed ID: 17042788 [TBL] [Abstract][Full Text] [Related]
13. Mutations of human topoisomerase II alpha affecting multidrug resistance and sensitivity. Mao Y; Yu C; Hsieh TS; Nitiss JL; Liu AA; Wang H; Liu LF Biochemistry; 1999 Aug; 38(33):10793-800. PubMed ID: 10451375 [TBL] [Abstract][Full Text] [Related]
14. Peptide sequencing and site-directed mutagenesis identify tyrosine-319 as the active site tyrosine of Escherichia coli DNA topoisomerase I. Lynn RM; Wang JC Proteins; 1989; 6(3):231-9. PubMed ID: 2560190 [TBL] [Abstract][Full Text] [Related]
15. A model for tumor cell killing by topoisomerase poisons. Zhang H; D'Arpa P; Liu LF Cancer Cells; 1990 Jan; 2(1):23-7. PubMed ID: 2167111 [TBL] [Abstract][Full Text] [Related]
16. DNA topoisomerase dysfunction: a new goal for antitumor chemotherapy. Smith PJ Bioessays; 1990 Apr; 12(4):167-72. PubMed ID: 2159289 [TBL] [Abstract][Full Text] [Related]
17. gyrB-225, a mutation of DNA gyrase that compensates for topoisomerase I deficiency: investigation of its low activity and quinolone hypersensitivity. Heddle JG; Lu T; Zhao X; Drlica K; Maxwell A J Mol Biol; 2001 Jun; 309(5):1219-31. PubMed ID: 11399091 [TBL] [Abstract][Full Text] [Related]
18. Linker insertion mutagenesis of Drosophila topoisomerase II. Probing the structure of eukaryotic topoisomerase II. Lee MP; Hsieh TS J Mol Biol; 1994 Jan; 235(2):436-47. PubMed ID: 8289273 [TBL] [Abstract][Full Text] [Related]
19. [Bacterial type II topoisomerases as targets for antibacterial drugs]. Pietrusiński M; Staczek P Postepy Biochem; 2006; 52(3):271-82. PubMed ID: 17201062 [TBL] [Abstract][Full Text] [Related]
20. [Topoisomerase I cleavage site in the regulatory zone of transcriptionally active minichromosomes of the SV40 virus located adjacent to a region, hypersensitive to DNAase I and segments recognizing topoisomerase II]. Vasetskiĭ ES; Kalandadze AG; Razin SV; Georgiev GP Dokl Akad Nauk SSSR; 1989; 306(6):1493-6. PubMed ID: 2553371 [No Abstract] [Full Text] [Related] [Next] [New Search]